2022 Genetics and mental health Healthcare 
Mad in America
OCTOBER 17, 2024
Unbalanced, for instance, in the sense that much emphasis is placed on brain and genetic studies that to this day have cost billions of dollars, while showing only very small associations—not providing any basis for biological screening. Genetic studies are also the cause of many misunderstandings.
Mad in America
FEBRUARY 24, 2024
P sychiatry’s serotonin-imbalance theory of depression, long discarded by researchers, was finally flushed down the toilet by psychiatry and the mainstream media in 2022. Less publicized in 2022 was another powerful discrediting of psychiatry’s neurobiological disease model.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
MARCH 20, 2024
Mad in America has previously examined the problems with conflicts of interest in research but this time we extend that to look at the potential effect of COIs on diagnostic tools such as the Diagnostic and Statistical Manual of Mental Disorders (DSM). We don’t see that in the mental health field.
Mad in America
AUGUST 5, 2024
Within this, some parts of the neurodiversity movement take an uncritical or neutral perspective on the validity of psychiatric diagnoses such as—but not limited to—ASD and ADHD, backed up by unsubstantiated claims about biological and genetic causal factors. The consequences for assessment and therapy were described in Part 3.
Mad in America
OCTOBER 18, 2023
R ay Moynihan is an accomplished health journalist and author who has won several awards for his work. Moynihan’s research and writing focus on the healthcare industry, with an emphasis on how diseases are created, branded, and marketed to unsuspecting people. This applies in the mental illness world and everywhere in medicine.
Expert insights. Personalized for you.
129 
Let's personalize your content